Avibactam potentiated the activity of both ceftazidime and aztreonam against S. maltophilia clinical isolates in vitro

抗生素 哌拉西林 他唑巴坦 体外 头孢吡肟 抗药性 亚胺培南 头孢噻肟 抗菌剂 头孢菌素
作者
Qiuxia Lin,Hua Zou,Xian Chen,Menglu Wu,Deyu Ma,Hanbing Yu,Siqiang Niu,Shifeng Huang
出处
期刊:BMC Microbiology [BioMed Central]
卷期号:21 (1): 1-6 被引量:6
标识
DOI:10.1186/s12866-021-02108-2
摘要

Treatment options for Stenotrophomonas maltophilia (S. maltophilia) infections were limited. We assessed the efficacy of ceftazidime (CAZ), ceftazidime-avibactam (CAZ-AVI), aztreonam (ATM), and aztreonam-avibactam (ATM-AVI) against a selection of 76 S. maltophilia out of the 1179 strains isolated from the First Affiliated Hospital of Chongqing Medical University during 2011–2018. We investigated the antimicrobial resistance profiles of the 1179 S. maltophilia clinical isolates from the first affiliated hospital of Chongqing Medical University during 2011–2018, a collection of 76 isolates were selected for further study of microbiological characterization. Minimum inhibitory concentrations (MICs) of CAZ, CAZ-AVI, ATM and ATM-AVI were determined via the broth microdilution method. We deemed that CAZ-AVI or ATM-AVI was more active in vitro than CAZ or ATM alone when CAZ-AVI or ATM-AVI led to a category change from “Resistant” or “Intermediate” with CAZ or ATM alone to “Susceptible” with CAZ-AVI or ATM-AVI, or if the MIC of CAZ-AVI or ATM-AVI was at least 4-fold lower than the MIC of CAZ or ATM alone. For the 76 clinical isolates included in the study, MICs of CAZ, ATM, CAZ-AVI and ATM-AVI ranged from 0.03–64, 1–1024, 0.016–64, and 0.06–64 μg/mL, respectively. In combined therapy, AVI was active at restoring the activity of 48.48% (16/33) and 89.71% (61/68) of S. maltophilia to CAZ and ATM, respectively. Furthermore, CAZ-AVI showed better results in terms of the proportion of susceptible isolates (77.63% vs. 56.58%, P < 0.001), and MIC50 (2 μg/mL vs. 8 μg/mL, P < 0.05) when compared to CAZ. According to our definition, CAZ-AVI was more active in vitro than CAZ alone for 81.58% (62/76) of the isolates. Similarly, ATM-AVI also showed better results in terms of the proportion of susceptible isolates (90.79% vs.10.53%, P < 0.001) and MIC50 (2 μg/mL vs. 64 μg/mL, P < 0.001) when compared to ATM. According to our definition, ATM-AVI was also more active in vitro than ATM alone for 94.74% (72/76) of the isolates. AVI potentiated the activity of both CAZ and ATM against S. maltophilia clinical isolates in vitro. We demonstrated that CAZ-AVI and ATM-AVI are both useful therapeutic options to treat infections caused by S. maltophilia.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
negolos发布了新的文献求助10
刚刚
CITY111119发布了新的文献求助10
刚刚
弗洛伊德完成签到,获得积分10
2秒前
合适的寻菡完成签到,获得积分10
3秒前
3秒前
嗒帅发布了新的文献求助10
4秒前
周周发布了新的文献求助10
5秒前
5秒前
tiankong完成签到,获得积分10
5秒前
常大有完成签到,获得积分10
6秒前
小钥匙完成签到 ,获得积分10
6秒前
rylinn完成签到,获得积分10
6秒前
爆米花的应助被风中的宛白采纳,获得10
7秒前
Owen的应助被风中的宛白采纳,获得20
7秒前
田様的应助被风中的宛白采纳,获得20
7秒前
7秒前
斯文败类的应助被风中的宛白采纳,获得10
7秒前
CipherSage的应助被风中的宛白采纳,获得20
7秒前
8秒前
传奇3的应助被风中的宛白采纳,获得20
8秒前
8秒前
zyy发布了新的文献求助30
10秒前
温文儒雅鳗鱼冻完成签到,获得积分10
11秒前
流苏完成签到,获得积分20
11秒前
13秒前
共享精神的应助被Erpan采纳,获得10
13秒前
13秒前
彭于晏的应助被Lynn采纳,获得10
13秒前
Holic完成签到,获得积分10
14秒前
zyy发布了新的文献求助10
15秒前
16秒前
yy发布了新的文献求助10
16秒前
焦小黑发布了新的文献求助10
17秒前
17秒前
xiaoluoluo完成签到,获得积分10
17秒前
斯文败类的应助被科研小白采纳,获得10
17秒前
终梦的应助被辛酸有很多种采纳,获得20
17秒前
fanfan发布了新的文献求助10
18秒前
chai完成签到,获得积分10
19秒前
zlll完成签到 ,获得积分10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181940
求助须知:如何正确求助?哪些是违规求助? 9571697
关于积分的说明 21819181
捐赠科研通 7778330
什么是DOI,文献DOI怎么找? 3433556
关于科研通互助平台的介绍 2557767
邀请新用户注册赠送积分活动 2479621